Elmsford, NY, United States of America

Jiaxi Wu

This inventor holds 8 USPTO granted patents and 15 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiaxi Wu. Retrieved from https://idiyas.com/inventor/jiaxi-wu-j84sii96

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Jiaxi Wu: Innovator in IL2 Agonists

Introduction

Jiaxi Wu is a prominent inventor based in Elmsford, NY (US). He has made significant contributions to the field of immunology, particularly through his work on IL2 agonists. With a total of 8 patents to his name, Wu is recognized for his innovative approaches to enhancing therapeutic profiles.

Latest Patents

Wu's latest patents include groundbreaking work on IL2 agonists and methods of use thereof. This patent focuses on IL2 agonists that exhibit improved therapeutic profiles, which could lead to more effective treatments for various conditions. Another notable patent is for IgG Fc-IL2-Rα-IL2 fusions, which also aims to enhance the therapeutic efficacy of IL2 agonists.

Career Highlights

Jiaxi Wu is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its focus on developing innovative medicines. His work at Regeneron has allowed him to collaborate with some of the brightest minds in the industry, further advancing the field of immunotherapy.

Collaborations

Some of Wu's notable coworkers include Tong Zhang and Maria Del Pilar Molina-Portela. Their collaborative efforts contribute to the innovative research environment at Regeneron Pharmaceuticals.

Conclusion

Jiaxi Wu's contributions to the field of immunology through his patents on IL2 agonists demonstrate his commitment to advancing medical science. His work not only highlights his innovative spirit but also underscores the importance of collaboration in achieving groundbreaking results.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…